Cargando…

Respiratory safety of lemborexant in healthy adult and elderly subjects with mild obstructive sleep apnea: A randomized, double‐blind, placebo‐controlled, crossover study

Lemborexant is a dual orexin receptor antagonist indicated for the treatment of adult and elderly individuals with insomnia. Some current pharmacologic treatments for insomnia cause respiratory depression, a serious safety concern, particularly for individuals with obstructive sleep apnea (OSA). Thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Jocelyn Y., Filippov, Gleb, Moline, Margaret, Zammit, Gary K., Bsharat, Mohammad, Hall, Nancy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Sleep Disordered Breathing
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507183/ https://www.ncbi.nlm.nih.gov/pubmed/32187781 http://dx.doi.org/10.1111/jsr.13021

Ejemplares similares

How does obstructive sleep apnea alter cerebral hemodynamics?
por: Gregori-Pla, Clara, et al.
Publicado: (2023)

Comparative associations of oximetry patterns in Obstructive Sleep Apnea with incident cardiovascular disease
por: Sutherland, Kate, et al.
Publicado: (2022)

Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea
por: Fox, Henrik, et al.
Publicado: (2019)

Swallowing and aspiration during sleep in patients with obstructive sleep apnea versus control individuals
por: Kohno, Akane, et al.
Publicado: (2022)

Displacement of the hyoid bone by muscle paralysis and lung volume increase: the effects of obesity and obstructive sleep apnea
por: Kohno, Akane, et al.
Publicado: (2018)

Discovery of genomic loci associated with sleep apnea risk through multi-trait GWAS analysis with snoring
por: Campos, Adrian I, et al.
Publicado: (2022)

The effect of obstructive sleep apnea therapy on cardiovascular autonomic function: a systematic review and meta-analysis
por: Dissanayake, Hasthi U, et al.
Publicado: (2022)

Obstructive sleep apnea is associated with coronary microvascular dysfunction: A systematic review from a clinical perspective
por: Zhang, Rui‐Heng, et al.
Publicado: (2020)

A multicentric validation study of a novel home sleep apnea test based on peripheral arterial tonometry
por: Van Pee, Bart, et al.
Publicado: (2022)

Abnormal brain iron accumulation in obstructive sleep apnea: A quantitative MRI study in the HypnoLaus cohort
por: Marchi, Nicola Andrea, et al.
Publicado: (2022)

Transvenous phrenic nerve stimulation is associated with normalization of nocturnal heart rate perturbations in patients with central sleep apnea
por: Baumert, Mathias, et al.
Publicado: (2023)

Assessment of obstructive sleep apnea-related sleep fragmentation utilizing deep learning-based sleep staging from photoplethysmography
por: Huttunen, Riku, et al.
Publicado: (2021)

Correlates of excessive daytime sleepiness in obstructive sleep apnea: Results from the nationwide SESAR cohort including 34,684 patients
por: Ulander, Martin, et al.
Publicado: (2022)

Overnight declarative memory consolidation and non-rapid eye movement sleep electroencephalographic oscillations in older adults with obstructive sleep apnea
por: Teh, Jun Z, et al.
Publicado: (2023)

Improvements in cognitive function and quantitative sleep electroencephalogram in obstructive sleep apnea after six months of continuous positive airway pressure treatment
por: D’Rozario, Angela L, et al.
Publicado: (2022)

Effect of alcohol coadministration on the pharmacodynamics, pharmacokinetics, and safety of lemborexant: A randomized, placebo-controlled crossover study
por: Landry, Ishani, et al.
Publicado: (2022)

Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2
por: Kärppä, Mikko, et al.
Publicado: (2020)

Effect of adaptive servo ventilation on central sleep apnea and sleep structure in systolic heart failure patients: polysomnography data from the SERVE‐HF major sub study
por: Tamisier, Renaud, et al.
Publicado: (2022)

Determinants of depressive mood in coronary artery disease patients with obstructive sleep apnea and response to continuous positive airway pressure treatment in non‐sleepy and sleepy phenotypes in the RICCADSA cohort
por: Balcan, Baran, et al.
Publicado: (2019)

Central apnea and periodic breathing in children with underlying conditions
por: Ghirardo, Sergio, et al.
Publicado: (2021)

Objective measurement of compliance during oral appliance therapy for sleep-disordered breathing
por: Vanderveken, Olivier M, et al.
Publicado: (2013)

Algorithm for automatic detection of self-similarity and prediction of residual central respiratory events during continuous positive airway pressure
por: Oppersma, Eline, et al.
Publicado: (2020)

Self‐reported symptoms of sleep‐disordered breathing and risk of cardiovascular diseases: Observational and Mendelian randomization findings
por: Titova, Olga E., et al.
Publicado: (2022)

In search of a better CPAP interface: A network meta‐analysis comparing nasal masks, nasal pillows and oronasal masks
por: Chen, Li‐Yang, et al.
Publicado: (2022)

Multimodal phenotypic labelling using drug‐induced sleep endoscopy, awake nasendoscopy and computational fluid dynamics for the prediction of mandibular advancement device treatment outcome: a prospective study
por: Van den Bossche, Karlien, et al.
Publicado: (2022)

Effects of oral appliance treatment on inflammatory biomarkers in obstructive sleep apnea: A randomised controlled trial
por: Hedberg, Pär, et al.
Publicado: (2020)

Influence and implications of the renin–angiotensin–aldosterone system in obstructive sleep apnea: An updated systematic review and meta‐analysis
por: Loh, Huai Heng, et al.
Publicado: (2022)

Rapid eye movement sleep apnea and carotid intima thickness in men and women: a SHE‐MUSTACHE cohort study
por: Ljunggren, Mirjam, et al.
Publicado: (2022)

Communication during the initial visit to a CPAP clinic Practitioners’ experiences of facilitators and barriers when talking to patients with obstructive sleep apnea
por: Broström, Anders, et al.
Publicado: (2020)

Effect of hepatic impairment on pharmacokinetics, safety, and tolerability of lemborexant
por: Dayal, Satish, et al.
Publicado: (2021)

Sleep apnea pathophysiology
por: Andrisani, Giovanni, et al.
Publicado: (2023)

Effect of severe renal impairment on pharmacokinetics, safety, and tolerability of lemborexant
por: Landry, Ishani, et al.
Publicado: (2021)

Preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on REM sleep behavior disorder in Parkinson’s disease
por: Meloni, Mario, et al.
Publicado: (2021)

Transoral awake state neuromuscular electrical stimulation therapy for mild obstructive sleep apnea
por: Nokes, Brandon, et al.
Publicado: (2022)

Obstructive sleep apnea syndrome in non-obese patients
por: Antonaglia, Caterina, et al.
Publicado: (2021)

On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers
por: Vermeeren, Annemiek, et al.
Publicado: (2018)

PAP treatment in patients with OSA does not induce long‐term nasal obstruction
por: Värendh, Maria, et al.
Publicado: (2018)

The relationship between obstructive sleep apnea hypopnea syndrome and gastroesophageal reflux disease: a meta-analysis
por: Wu, Zeng-Hong, et al.
Publicado: (2018)

Contribution of central sleep apnea to severe sleep apnea hypopnea syndrome
por: Zhang, Guoxin, et al.
Publicado: (2023)

Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial
por: Rosenberg, Russell, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qp8ohrog80oe7q1ua17o6fkt9d